Switzerland today approved the vaccination of children aged 12-15 years with vaccine against Covid-19 of Pfizer and BioNTEch, in view of the country’s plan to start vaccinating its youngest citizens in July.
“Swissmedic has carefully considered the application P submitted by Pfizer,” the regulator said in a statement after issuing a temporary, formal authorization for the vaccine. 12-15 years old.
The vaccine, as for people over the age of 16, should be given in two doses, following clinical trials that have shown about 100% effectiveness in the younger age group, according to Swissmedic.
Swiss officials have said they hope to begin vaccinating 12- to 15-year-olds this summer to prepare students for the 2021-2022 school year and help reduce a possible outbreak of the virus ahead of winter.
“The more people are vaccinated, and the more children are part of it, the less the virus will circulate and the lower the risk for vulnerable groups,” the Swiss health ministry told Reuters, answering questions about the strategy. for the children.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
